RCMT vs TBI

For growth investors, RCM Technologies, Inc.

(RCMT) is the stronger pick with 14. 7% revenue growth year-over-year, versus 3. 1% for TrueBlue, Inc. (TBI). RCM Technologies, Inc. (RCMT) offers the better valuation at 13. 3x trailing P/E (12. 3x forward), making it the more compelling value choice. Analysts rate RCM Technologies, Inc. (RCMT) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, RCM Technologies, Inc.

(RCMT) delivered a total return of +712. 2%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: RCMT returned +466. 9% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), TrueBlue, Inc.

(TBI) is the lower-risk stock at 1. 13β versus RCM Technologies, Inc. 's 1. 30β — meaning RCMT is approximately 15% more volatile than TBI relative to the S&P 500. On balance sheet safety, RCM Technologies, Inc. (RCMT) carries a lower debt/equity ratio of 56% versus 62% for TrueBlue, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), RCM Technologies, Inc.

(RCMT) is pulling ahead at 14. 7% versus 3. 1% for TrueBlue, Inc. (TBI). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to 28. 0% for RCM Technologies, Inc.. Over a 3-year CAGR, RCMT leads at 3. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

RCM Technologies, Inc.

(RCMT) is the more profitable company, earning 5. 1% net margin versus -3. 0% for TrueBlue, Inc. — meaning it keeps 5. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RCMT leads at 7. 9% versus -1. 7% for TBI. At the gross margin level — before operating expenses — RCMT leads at 26. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, RCM Technologies, Inc.

(RCMT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+466. 9% 10Y return). Both have compounded well over 10 years (RCMT: +466. 9%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: RCMT is a small-cap deep-value stock; TBI is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.